Prescient Therapeutics LimitedASX: PTX

FDA IND Re-Activation Request for Phase Ib/II Trial

· Issued by Prescient Therapeutics Limited

Filed with ASX ·

On 6ix: 6ix.com/news/fda-ind-re-activation-request-for-phase-ibii-trial

6ix hasn’t read this filing yet.

Prescient Therapeutics Limited on 6ix